{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:52:04Z","timestamp":1765295524409,"version":"3.30.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.diagmicrobio.2024.116607","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T14:29:44Z","timestamp":1731767384000},"page":"116607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between the recurrence rate of genital warts and administration of quadrivalent human papilloma virus vaccine in women"],"prefix":"10.1016","volume":"111","author":[{"given":"Fatemeh Momeni","family":"Asl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvin","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4767-6596","authenticated-orcid":false,"given":"Mitra","family":"Safari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116607_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0956462420958577","article-title":"Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination","volume":"32","author":"Tyros","year":"2021","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116607_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"De Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0003","unstructured":"Organization WH. Global strategy for the prevention and control of sexually transmitted infections: 2006-2015: breaking the chain of transmission. 2007."},{"issue":"12","key":"10.1016\/j.diagmicrobio.2024.116607_bib0004","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"Am Fam Physician"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116607_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132404","article-title":"Evaluating the early benefit of quadrivalent HPV vaccine on genital warts in Belgium: a cohort study","volume":"10","author":"Dominiak-Felden","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116607_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5114\/ada.2019.82915","article-title":"Determinants of high-risk human papillomavirus infection in anogenital warts","volume":"36","author":"Ozaydin-Yavuz","year":"2019","journal-title":"Advances in Dermatology and Allergology\/Post\u0119py Dermatologii i Alergologii"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116607_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.26488","article-title":"Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran","volume":"131","author":"Khodakarami","year":"2012","journal-title":"Int J Cancer."},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0008","unstructured":"Jamali ZM, Hamkar R, Ghobadi DV, Delforoush M, Shoja MM, Modares GM. Prevalence of HPV infection and its association with cytological abnormalities of pap smears in Tehran. 2008."},{"issue":"9","key":"10.1016\/j.diagmicrobio.2024.116607_bib0009","first-page":"518","article-title":"Genital warts in 250 Iranian patients and their high-risk sexual behaviors","volume":"16","author":"Soori","year":"2013","journal-title":"Arch Iran Med"},{"issue":"9769","key":"10.1016\/j.diagmicrobio.2024.116607_bib0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0140-6736(10)62342-2","article-title":"Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study","volume":"377","author":"Giuliano","year":"2011","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116607_bib0011","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/sextrans-2011-050306","article-title":"Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain","volume":"88","author":"Johnson","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjose","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11591170-000000000-00000","article-title":"Economic and humanistic burden of external genital warts","volume":"30","author":"Raymakers","year":"2012","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116607_bib0014","first-page":"686","article-title":"Study on the impact of sexually transmitted infections on quality of Life, mood and sexual function","volume":"156","author":"Ciccarese","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116607_bib0015","first-page":"107","article-title":"Genital warts: new approaches to the treatment\/genitalne bradavice-novi pristupi u le\u010denju","volume":"1","author":"Golu\u0161in","year":"2009","journal-title":"Serb J Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116607_bib0016","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2\u20133)?","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116607_bib0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D37V57P744","article-title":"Genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Online J"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116607_bib0018","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116607_bib0019","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0956462420920142","article-title":"Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis","volume":"31","author":"Husein-ElAhmed","year":"2020","journal-title":"Int J STD AIDS"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2024.116607_bib0020","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.3802\/jgo.2021.32.e94","article-title":"Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines","volume":"32","author":"Cho","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0021","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00404-018-4926-y","article-title":"Indication of prophylactic vaccines as a tool for secondary prevention in HPV-linked disease","volume":"298","author":"Pieralli","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116607_bib0022","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated Human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0023","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.3390\/jcm12134230","article-title":"Treatment of pediatric anogenital warts in the era of HPV-vaccine: A literature review","volume":"12","author":"Herzum","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0024","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jaad.2011.11.970","article-title":"Lack of efficacy in treating condyloma acuminata and preventing recurrences with the recombinant quadrivalent human papillomavirus vaccine in a case series of immunocompetent patients","volume":"68","author":"Kreuter","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2024.116607_bib0025","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1111\/jsm.12670","article-title":"Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV infection: a randomized study","volume":"11","author":"Coskuner","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2024.116607_bib0026","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/vaccines10020239","article-title":"HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis","volume":"10","author":"Di Donato","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0027","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1590\/s1677-5538.ibju.2018.0355","article-title":"Can quadrivalent human papillomavirus prophylactic vaccine be an effective alternative for the therapeutic management of genital warts? An exploratory study","volume":"45","author":"Choi","year":"2019","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0028","doi-asserted-by":"crossref","first-page":"e13771","DOI":"10.1111\/dth.13771","article-title":"Nonavalent human papillomavirus vaccination as alternative treatment for genital warts","volume":"33","author":"Bossart","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0029","first-page":"67","article-title":"Efficacy of nonavalent human papillomavirus vaccine for recalcitrant warts","volume":"158","author":"Dianzani","year":"2023","journal-title":"Ital J Dermatol Venerol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2024.116607_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.japh.2023.10.028","article-title":"A systematic review of the treatment of active anogenital warts with human papillomavirus vaccines","volume":"64","author":"Villemure","year":"2003","journal-title":"J Am Pharm Assoc"},{"issue":"23","key":"10.1016\/j.diagmicrobio.2024.116607_bib0031","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.3390\/jcm12237317","article-title":"Efficacy of Human papillomavirus vaccines for recalcitrant anogenital and oral warts","volume":"12","author":"Ciccarese","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0032","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00404-019-05242-5","article-title":"Recurrence of genitals warts in pre-HPV vaccine era after laser treatment","volume":"300","author":"Widschwendter","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.diagmicrobio.2024.116607_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00430-003-0181-2","article-title":"Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts","volume":"193","author":"Gross","year":"2004","journal-title":"Med Microbiol Immunol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116607_bib0034","first-page":"745","article-title":"Analysis of the relationship between clinical features, treatment options and recurrence of patients diagnosed with anogenital warts","volume":"6","author":"Saadet","year":"2021","journal-title":"J Health Sci Med"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324004310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T20:34:23Z","timestamp":1733517263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324004310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0732889324004310"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116607","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between the recurrence rate of genital warts and administration of quadrivalent human papilloma virus vaccine in women","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116607"}}